Imaging & Oncology Convention

NEC

26 & 27

MARCH

BIRMINGHAM

TUES | 10am - 5pm | WEDS - 10am - 4pm

BIRMINGHAM 2019

HEAD & NECK

300 LEADING EXHIBITORS

GI

LUNG

BREAST

GU BIRMINGHAM 2019

4,500 VISITORS

INTERACTIVE

200

MASTERCLASSES & WORKSHOPS

CPD - ACCREDITED SEMINARS

AI & MACHINE LEARNING

THE UK’S LARGEST MEDICAL EVENT

FOR CLINICIANS AND SENIOR MANAGEMENT TEAMS MAIN SPONSOR:

@MedImagingCon #MedImaging19 | @OncologyExpo #Oncology19

WELCOME TO THE MEDICAL IMAGING CONVENTION AND EUROPEAN ONCOLOGY CONVENTION

HEAD & NECK

BIRMINGHAM 2019

GI

LUNG

BREAST

GU BIRMINGHAM 2019

Across the two days of the European Oncology Convention and the Medical Imaging Convention, 4,500 clinical professionals and their management teams will come together with the shared focus of improving patient outcomes. Discover the latest research, practice, technology, products and services that are shaping the future of healthcare. As the NHS gets to grips with its’ new Long Term Plan and budget, the European Oncology Convention and the Medical Imaging Convention will help the sector now by providing 200 free to attend CPD accredited seminars. Alongside the complimentary CPD accreditation, all the technology on exhibit has been chosen explicitly for its potential to make immediate impacts on hospital services and patient outcomes across the prevention, diagnosis, treatment, and care patient pathway.

This unique event will put the latest advances in research and practice centre stage. Visitors have the opportunity to study new techniques and experience groundbreaking technology from world-leading clinical experts and exclusively chosen exhibitors. Every CPD accredited seminar across the European Oncology Convention and the Medical Imaging Convention provides an opportunity to gain insight into the dedicated focus topics of both events. For the European Oncology Convention, the focuses include Head & Neck, Lung, Breast, Gastrointestinal, and Genitourinary. The Medical Imaging Convention focusses on AI and Machine Learning, MRI & CT, Ultrasound, Medical Physics, X-Ray, and, PACS & IT Systems.

At the European Oncology Convention and Medical Imaging Convention, leading healthcare companies will showcase the products, services and technology helping to change the lives of current and future patients. By providing access to such advanced technology, this event works toward improving the efficiency of oncology and imaging department services; improving patient outcomes as a result. We are delighted to be working alongside our headline sponsor Philips, to bring you a comprehensive event complete with exhibits from 300 pioneering companies and access to innovative technology, that will shape the future and direction of healthcare.

The CPD accredited educational stream is bolstered by training opportunities in masterclasses run by the Rutherford Cancer Centres.

Each masterclass will compliment the learning outcomes from the CPD accredited seminars by providing training on the subjects they have just learnt about.

The European Oncology Convention and the Medical Imaging Convention are both platforms for specialists to experience the cutting edge of these advancing industries; a free opportunity to experience the advances towards effective, efficient hospitals delivering exceptional patient outcomes.

RUNNING ALONGSIDE

DIAGNOSTIC SURGICAL REHABILITATION BRAIN STIMULATION

PART OF

BIRMINGHAM 2019

MEDICAL

Simon McGui re Philips Healt h Systems Leader UK& I

PAGE PAGE

AI & MACHINE LEARNING

PAGE

ONCOLOGY SPEAKERS

PAGE

MASTERCLASSES

PAGE

TIMETABLE

PAGE

MIC provides a great platform for imaging pro fessionals to hear direc tly from their industry exp peers and erts about th e challenges solutions tha and t are in play, both now, an the future. Fo d in r us as Platin um Sponsor, gives us the it opportunity to foster new a existing rela nd tionships wh ilst showcasi how we can ng help address these ever-evolvin g imaging nee ds.

KEYNOTE SPEAKERS

EXHIBITORS & FLOOR PLAN

MOIRA CROTTY BIRMINGHAM 2019

KEYNOTE SPEAKERS The Medical Imaging Convention’s CPD accredited seminars will be led by experts who have dedicated their lives to the progression of medical imaging and improving patient outcomes.

Every keynote speaker on the schedule has been chosen specifically for the exceptional work in their specialist field. Visitors will receive second to none insight into topics that spread across the diagnosis and treatment themes of the event. There will be relevance to European Oncology Convention visitors with topics covering the equipment that will become integrated into Imaging and Oncology departments.

WEDNESDAY | KEYNOTE THEATRE 1 | 14.45

NHS DIGITAL LEAD PROGRAMME MANAGER Having started out as a diagnostic radiographer, Moira Crotty has spent the last 20 years procuring, implementing and managing imaging and diagnostic IT systems, on behalf of the NHS and private sectors.

As a Programme Manager for NHS Digital she led the latter stages of the National PACS Programme.

Moira is currently developing a toolkit for NHS Imaging services looking to move to networked operational models.

IT AND INFORMATICS TOOLKIT FOR IMAGING NETWORKS Provision of NHS imaging services using the model of a regional network has been a subject of growing interest in recent years. Achieving the objectives of such operational models is critically dependent on IT infrastructure and systems, both existing and new.

NHS Digital is developing a toolkit to assist NHS Trusts in understanding and leveraging their existing environment, and potentially procuring new additional elements to meet the aims of their network.

SPONSORED BY

DR MED. CHRISTOPH JULI

CONSULTANT CARDIAC RADIOLOGIST

ALSO ON: WEDNESDAY | THEATRE 1 | 11.00

Currently responsible for the world wide first clinical implementation of the 1.5 T Ingenia Ambition X MRI System, Dr Juli is also consulting for Preventicum London, where he is responsible for reviewing and reporting the Cardiac MRI imaging.

After graduating from the University of Frankfurt, Dr Juli undertook his Cardiology and Radiology training in Switzerland and the UK. He is CBCCT certified, regularly attending national and international conferences in the field of Cardiothoracic Imaging.

DIAGNOSTIC SURGICAL REHABILITATION BRAIN STIMULATION

HEAD & NECK

GI

LUNG

BREAST

BIRMINGHAM 2019

GU BIRMINGHAM 2019

MEDICAL 4

TUESDAY | KEYNOTE THEATRE 1 | 14.00

COMPRESSED SENSE CARDIAC MAGNETIC RESONANCE (CMR) IMAGING WITH THE 1.5T AMBITION X BLUESEAL MAGNET Compressed SENSE is a breakthrough imaging acceleration technique speeding up not only sequences but the entire exam. This talk is dedicated to illustrate its usefulness in clinical CMR and its implementation on the 1.5T Ambition X. Demonstration of how the excellent homogeneity of the BlueSeal magnets 55cm field-of-view can be used to answer the most challenging CMR imaging demands.

SPONSORED BY

PROFESSOR IRIS QUASAR GRUNWALD

CONSULTANT NEURORADIOLOGIST AND ASSOCIATE MEDICAL DIRECTOR

RACHAEL HINCHLIFFE

Professor Iris Quasar Grunwald is the Consultant Neuroradiologist and Associate Medical Director at Southend University and Director of Neuroscience at Anglia Ruskin University School of Medicine.

She has published well over 150 papers and several book chapters, mainly in the field of neurointervention and pre-hospital care. Through her extensive work, Prof. Grunwald has built an international reputation as a foremost expert in acute stroke services.

PLAIN FILM REPORTING ADVANCED PRACTITIONER

WEDNESDAY | KEYNOTE THEATRE 1 | 12.30 WEDNESDAY | KEYNOTE THEATRE 1 | 14.00

THE UK'S 1ST MOBILE STROKE UNIT – IS THIS THE FUTURE? Prof. Iris shares her experience of running the first mobile stroke unit in the UK. This is an ambulance equipped with a CT scanner, point of care lab and telemedicine and is the first of its kind in the UK, making this seminar a unique opportunity to hear insights into this national first.

TERRY JONES

MEDICAL PHYSICIST Terry Jones is a medical physicist who, as visiting professor at The University of California, Davis, has been involved in the development of the world’s first Total Body PET Scanner known as u EXPLORER.

TUESDAY | KEYNOTE THEATRE 1 | 13.15

Terry helped to establish the UK’s first PET scanner program in the 1970s, at Hammersmith Hospital, London, making him highly experienced in this particular area of imaging. He has over 300 scientific publications with a h-index of 82, and is a fellow of the UK’s Academy of Medical Sciences

U EXPLORER: THE WORLD'S FIRST TOTALBODY PET SCANNER Terry will present the first static and dynamic human scans performed by the u EXPLORER PET Scanner. He will explain how the technology will: detect lower levels of focal pathology, reduce radiation doses, the time taken to scan, simultaneously record the total body’s regional tissue function thereby providing unrivalled means for molecular imaging in clinical research and healthcare.

After training as a Diagnostic Radiographer in a major trauma centre in the West Midlands Rachael’s passion for Plain Film and Plain Film Advanced Practice was ignited early on, after being inspired by some of the first Plain Film Reporting Radiographers in the region.

After working as a Plain film and Nuclear Medicine Radiographer early in her career, she was fortunate to commence training in the mid-2000s to become a Plain Film Reporting Advanced Practitioner, and has been very privileged to have been undertaking Advanced Practice in Plain Film Radiography for the last 14 years.

Within Rachael’s clinical practice she reports appendicular and axial musculoskeletal images and plain film images of the adult chest and abdomen. As well as the clinical elements of her role, she works as the Plain Film Modality Lead for HGS, which is a very diverse role offering many challenges within the plain film service and is most definitely a role that will always keep her busy!

PLAIN FILM SERVICE CHALLENGES? - HOW DO DIGITAL IMAGING SYSTEMS HELP? This is a discussion piece around the implementation of a new digital imaging system within the Trust, and how both hardware and software technological advancement supports plain film service challenges, and facilitates improvements in the patient pathway.

5

LAURA ALLINGTON

OPERATIONAL LEAD FOR PROTON BEAM THERAPY Since moving to UCLH in 1999, Laura Allington has held a number of positions across both the pre-treatment and treatment areas of radiotherapy.

For the past 16 years she has played key roles in implementing new treatment techniques and influencing changes in practice within the department. Since 2015, Laura has been involved in all aspects of developing the NHS UK proton service which has included equipment procurement, patient pathway design, workforce modelling and patient engagement.

OPERATIONAL CHALLENGES OF PLANNING A NEW NHS HIGH ENERGY PROTON SERVICE University College London Hospitals NHS Foundation Trust is working to implement the NHS high energy proton therapy service with The Christie NHS Foundation Trust.

Laura will be able to give a detailed overview from her position as Operational Lead on the implementation of proton beam therapy at UCLH.

TUESDAY | KEYNOTE THEATRE 1 | 12.30

PROFESSOR KAREN J KIRKBY

WEDNESDAY | KEYNOTE THEATRE 1 | 13.15

RESEARCH LEAD FOR PROTON THERAPY IN MANCHESTER Professor Karen Kirkby holds a joint post between the University of Manchester and the Christie Hospital as the research lead for proton therapy research.

Karen has a research grant portfolio of over £15M and over 190 papers in peer reviewed journals, including Nature. She has also written for popular science magazines and the broadsheets.

PROTON BEAM THERAPY IN MANCHESTER: THE STORY SO FAR Being the research lead for proton therapy at The University of Manchester, Prof. Karen J Kirkby will be looking into the research of the clinical proton beam centre at The Christie NHS Foundation Trust. Prof. Karen J Kirkby is a true authority on this topic and will lead a deeply interesting seminar filled with expert observations on a developing project.

ERNESTO A. CERDENA, PHD

CORPORATE DIRECTOR OF RADIOLOGY SERVICES TUESDAY | KEYNOTE THEATRE 1 | 11.45 Dr. Ernesto Cerdena has been in the field of medical imaging for 32 years. Currently, he serves as a Corporate Director of Radiology Services at Atlanticare Regional Medical Center in New Jersey USA, a member of the Geisinger Health.

He also serves as adjunct professor at University of Texas MD Anderson Cancer Center teaching Strategic Management and Health Resources and Policy Analysis.

6

CHALLENGES AND SUCCESS IN ADOPTING CLINICAL DECISION SUPPORT MECHANISM IN DIAGNOSTIC IMAGING The Clinical Decision Support Mechanism connects ordering clinicians with evidence-based guidance directly in the ordering workflow, helping to improve quality of care.

This topic addresses the pitfalls and accomplishments of early adoption of Clinical Decision Support Mechanism.

The discussion will share common barriers of CDSM adoption with a number of factors in order to effectively meet hospital quality programmes.

DR. SERGUEI SEMENOV

DR. SARAH BRÜNINGK

THE INSTITUTE OF CANCER RESEARCH POST DOCTORAL TRAINING FELLOW Sarah completed a M.Sc. in Physics (Biophysics) at the Technische Universität München with the major focus on bio-medical and soft matter physics.

Having worked in a medical physics group throughout her degree, she joined the clinical medical physics staff in the radiotherapy department at the Klinikum rechts der Isar in Munich until starting a PhD at the Institute of Cancer Research in October 2014.

Her PhD focused on modelling and quantifying biological response to combination treatments of focused ultrasound mediated hyperthermia and radiotherapy. Since 2018 Sarah has been working as a Post Doctoral Training Fellow at the Institute of Cancer Research working on biology guided treatment planning for multimodality therapies.

TUESDAY | KEYNOTE THEATRE 1 | 14.45

THE ROLE OF ULTRASOUND THERAPY IN CANCER TREATMENTS Therapeutic ultrasound is a non-invasive, localized technique to deliver heating and/ or mechanical stress deep into tissue. Applications for cancer therapy range from pain palliation to disease eradication using a variety of techniques including hyperthermia, drug delivery enhancement, ablation (of tumour or nerves), and mechanical tissue disruption (histotripsy). It can be deployed either as single modality or in combination with other treatments, such as radiotherapy.

PROFESSOR FENG WU HONORARY HIFU CONSULTANT AND SENIOR CLINICAL SCIENTIST UNIVERSITY OF OXFORD Professor Feng Wu (MD & PhD) began his research career in high intensity focused ultrasound (HIFU) therapy in 1988, and developed his own clinical prototype HIFU device in China, with his work largely dedicated to treating patients with solid tumours, including those of the liver, kidney, breast, pancreas, uterus, bone and soft tissues.

In 2012, he was invited to help establish the first clinical HIFU Unit in the UK, and to assist in running clinical trials for the HIFU treatment of patients with solid malignancies in Churchill Hospital, Oxford University Hospitals. He is currently working as Honorary HIFU Consultant at Oxford University Hospitals, and also serving as Senior Clinical Scientist at Nuffield Department of Surgical Sciences, University of Oxford. He has published more than 200 papers in peer-reviewed journals, and received the William and Francis Fry Award in 2013 for his outstanding contributions to the field.

TUESDAY | KEYNOTE THEATRE 1 | 11.00

FOCUSED ULTRASOUND THERAPY FOR TUMOURS: CURRENT STATUS AND FUTURE PROSPECTIVE As a non-invasive procedure, focused ultrasound therapy has been increasingly used for treating patients with solid tumours. It employs focused ultrasound beam to treat a targeted tumour at depth without any damage to surrounding tissues.

This presentation reviews focused ultrasound therapy with respect to its emerging clinical applications and future prospects. It also introduces an up-to-date clinical status in Oxford, ranging from tumour thermal ablation to targeted drug delivery.

PROFESSOR OF IMAGING WEDNESDAY | KEYNOTE THEATRE 1 | 11.45 Dr. Semenov and his team have developed Electromagnetic Tomography for biomedical applications since the early 1990s at the Carolinas Medical Center, Charlotte, NC, USA, then at Keele University, School of Medicine, Staffordshire, UK. In 2012 Dr. Semenov with his partners incorporated EMTensor GmbH, located in Vienna, Austria, as a vehicle to further R&D and commercialize EMT technology.

As well as this, Dr. Serguei has authored and co-authored dozens of peer-reviewed publications.

ELECTROMAGNETIC TOMOGRAPHY FOR BRAIN IMAGING Electromagnetic Tomography is a novel imaging technology that has recently emerged into various clinical applications, most recently including brain imaging. This seminar will explore the sensitivities of tissue blood, water content, malignancies and other issues that can affect the outcome of the image. The research and development of human brain imaging will be discussed as well, as Dr. Serguei begins looking at how future applications will work.

7

PAMELA BLACK BIRMINGHAM 2019

MEDICAL IMAGING SHOW SPEAKERS Spread across 4 theatres, the Medical Imaging Convention seminar schedule is made up of industry-leading clinical experts, all working to bring unprecedented advances into the Imaging industry.

Across the dedicated focus topics of AI and Machine Learning, MRI & CT, Ultrasound, Medical Physics, X-Ray, and, PACS & IT Systems, these speakers will deliver unparalleled insight into the latest techniques and equipment being used by experts now.

GARY ROYLE PROFESSOR OF CANCER THERAPY/ DIRECTOR OF RESEARCH FOR PROTON AND RADIOTHERAPY WEDNESDAY | THEATRE 13 | 13.15 Gary Royle is professor of Cancer Therapy at UCL and is director of research for proton and radiotherapy for both UCL and UCL Hospital. He is joint chair of UCL’s cancer network and is responsible for multidisciplinary research in cancer alongside being a member of several national and international committees for proton and radiotherapy.

NOVEL IMAGING AND SENSOR SYSTEMS FOR RADIOTHERAPY This seminar will explain the clinical requirements for imaging cancer patients undergoing radiotherapy and explore the various methods and technologies in current usage. Limitations will be discussed and current developments for improved solutions will be presented. Gary’s role in both national and international committees and networks guarantees his position at the forefront of knowledge surrounding the topic of radiotherapy.

8

CHAIR OF RADIOLOGY & ONCOLOGY Pam is a radiographer whose career spans many years, mainly in and around Liverpool. She became a Radiology Manager in 2002 and worked in North Wales before taking up a post at Aintree University Hospital.

Pam was President of the Society of Radiographers 201314, a UK Council member for the SoR for 7yrs, a member of the College Board of Trustees and was Chair of the Clinical Imaging Board 2015.

WEDNESDAY | THEATRE 13 | 11.45

IMPROVING RADIOLOGY SERVICES: A LOCAL PERSPECTIVE How can Radiology Services improve whilst becoming more cost effective and not heaping more pressure onto the staff that make up a Radiology Department? In an era where constant change is the only consistent across the NHS, this seminar plans to discuss the changes introduced into one Radiology Department to try to meet the demands of a Health Care Service under extreme pressure.

DR ANDREW BAGSHAW READER IN IMAGING NEUROSCIENCE AND CODIRECTOR OF THE CENTRE FOR HUMAN BRAIN HEALTH Dr. Andrew Bagshaw’s main interest is in developing and applying non-invasive brain imaging methods to questions in clinical and behavioural neuroscience, with a particular emphasis on using EEGfMRI to understand how the brain is affected by epilepsy and sleep.

Dr Bagshaw trained as a physicist at the Universities of Birmingham and Manchester, before moving on to positions at City University, University College London and the Montreal Neurological Institute.

MULTIMODAL NEUROIMAGING: METHODS AND APPLICATIONS OF COMBINED EEG-FMRI Functional MRI (fMRI) and electroencephalography (EEG) are two of the most widely used techniques for studying human brain function, and are based on changes in haemodynamic and electrophysiological activity respectively. While each provides a crucial window into brain function, combining them has the potential to give more detailed spatiotemporal information. The advantages and disadvantages of combined EEG-fMRI will be discussed, along with applications in basic and clinical neuroscience.

TUESDAY | THEATRE 14 | 11.45

DR HEATHER WILLIAMS PRINCIPAL MEDICAL PHYSICIST FOR NUCLEAR MEDICINE Dr Heather Williams is a Principal Medical Physicist for Nuclear Medicine at The Christie Hospital and Honorary Lecturer at the University of Manchester, focussing on teaching imaging physics and PET research. Heather is also a Director of ScienceGrrl, STEMNET ambassador, and active member of the IPEM Nuclear Medicine Special Interest Group and likes standing up and talking about science, and encouraging others (particularly women) to do so.

TUESDAY | THEATRE 13 | 12.30

STATE OF THE ART POSITRON EMISSION TOMOGRAPHY Positron Emission Tomography (PET) provides 3D maps of tissue function which are used routinely for diagnosis and response assessment in oncology, and to a lesser extent, cardiology and neurology. The technology required to capture these images is constantly in development. In this seminar, Heather sums up recent innovations in PET and how they are expected to benefit patients.

PROFESSOR ALAN PERKINS CLINICAL PROFESSOR OF MEDICAL PHYSICS Professor Alan Perkins is Clinical Professor of Medical Physics in the School of Medicine at the University of Nottingham and Honorary Consultant Clinical Scientist at Nottingham University Hospitals NHS Trust, where he is a Divisional Lead for Research and Innovation. He has had over 35 years experience in Nuclear Medicine and Medical Physics and broad managerial experience in the National Health Service.

HYBRID OPTICAL-GAMMA CAMERA IMAGING IN NUCLEAR MEDICINE This presentation describes the development of a novel camera for hybrid optical-gamma imaging, undertaken through a collaboration between Prof John Lees (University of Leicester) and Prof Alan Perkins (University of Nottingham). The hybrid camera comprises a 0.5mm thick CsI(Tl) columnar scintillator coupled to an electron multiplying CCD. A pinhole collimator and optical camera provide coaligned fused images. The design, operation and clinical prospects for such devices will be described.

TUESDAY | THEATRE 13 | 11.45

WAI LUP WONG CONSULTANT RADIOLOGIST/ SENIOR LECTURER Wai Lup Wong has published extensively on cancer including in the New England Journal of Medicine, contributed to textbooks including the most recent edition of Scott Brown’s Otolaryngology and is co-author of the current NICE upper aerodigestive tract cancer guidelines. Wai Lup is referee for the NIHR-HTA Programme. Passionate about improving patient experience, he led the team which developed the patient experience questions which will be mandated on all NHSE PET/CT patient experience surveys.

PET CT IN THE SURVEILLANCE OF PEOPLE WITH HEAD AND NECK CANCER Drawing from a survey of the published literature, the seminar will provide a review of the current role of FDG PET/CT following chemo-radiotherapy in people with advanced head and neck cancer. It will also give an update on the emerging role of FDG PET/CT in the follow-up of other people with head and neck cancer.

TUESDAY | THEATRE 14 | 12.30

PROFESSOR JAMES O’CONNOR PROFESSOR OF RADIOLOGY James O’Connor is Professor of Radiology at The University of Manchester, UK and a Cancer Research UK (CRUK) Advanced Clinician Scientist Fellow. He co-leads the CRUK National Cancer Imaging Translational network that links seven leading centres of cancer imaging research together in the UK. He graduated in medicine from the University of Cambridge, UK, and University of London, UK.

SPONSORED BY

DEVELOPING A NEW MRI METHOD OF TRACKING HYPOXIA IN CANCER

ANDY ROGERS LEAD INTERVENTIONAL MPE Andy Rogers is currently the Lead Interventional MPE at Nottingham University Hospitals NHS Trust and the immediate past-President of the British Institute of Radiology. He currently chairs the UK working group investigating how best to set DRLs in interventional procedures. He was recently on an international standards organisation IEC working group to represent the UK in a project looking at the use of dose data held in digital imaging modalities.

Oxygen deprivation (hypoxia) causes treatment resistance and poor clinical outcome in most solid tumours. Imaging methods are required to identify, quantify and track change in hypoxia, while also being cost-effective and readily available to healthcare providers. This seminar describes the emerging technology ‘Oxygen-enhanced MRI’.

Current evidence that this technology detects and maps radiation, and drug-induced hypoxia modification, are discussed along with future applications, such as guiding adaptive radiotherapy planning.

WEDNESDAY | THEATRE 14 | 12.30

IRIS ASLLANI RESEARCH MRI PHYSICIST

INTEGRATING INTERVENTIONAL PROCEDURE DATA TO IMPROVE CLINICIAN FEEDBACK – NEW TECHNOLOGY GAINS MATURITY Nottingham has utilised a rich source of data to improve cardiologist radiation safety awareness and culture. The technology employed is the Philips DoseWise Portal linked to DoseAware radiation dosimeters. Andy Rogers and his team have developed a reporting tool that allows clinicians to see their performance in key areas – this continual feedback allows continuous scrutiny on radiation and technique issues. The tool has allowed for discussions with trainees regarding radiation protection and clinical technique.

TUESDAY | THEATRE 13 | 11.00

Upon receiving her Bachelor’s degree in Theoretical Nuclear Physics from the University of Tirana in Albania, Dr. Asllani was awarded a Fulbright scholarship to pursue her Master’s and PhD in Bioengineering at the University of Washington in Seattle, Washington. Following her graduate studies, she joined Columbia University’s then newly established MRI centre where she spearheaded the Arterial Spin Labeling Perfusion MRI program.

TUESDAY | THEATRE 14 | 14.00

MULTIMODAL FUNCTIONAL IMAGING OF THE DISEASED BRAIN The primary goal of clinical MRI is the development of effective biomarkers that can distinguish the diseased brain from its normal counterpart in early stages. To this end, several methods have been developed that can measure various aspects of the brain’s structure and function. This talk will focus on recent efforts to integrate these methods, including non-MRI based ones, to provide a comprehensive and quantitative assessment of the diseased brain.

9

DR HUGH HARVEY CLINICAL DIRECTOR Dr Harvey is a board certified radiologist and clinical academic, trained in the NHS and Europe’s leading cancer research institute, the ICR, where he was twice awarded Science Writer of the Year. He is now a Royal College of Radiologists informatics committee and AI advisory board member, and the clinical director at Kheiron Medical.

DEEP LEARNING IN BREAST CANCER SCREENING An industry perspective of the challenges and pitfalls in developing and deploying deep learning algorithms within the NHS breast cancer screening programme. Dr Harvey brings an experienced view into the future of deep learning in breast cancer screening which will greatly benefit the NHS in the coming years.

THEATRE 9 AI TUESDAY | 14.00

AI THEATRE

AI THEATRE

ARTIFICIAL INTELLIGENCE (AI) & MACHINE LEARNING 10

HERE ARE THE TOP 5 AI KEYNOTES YOU DON'T WANT TO MISS

DR MATTHEW FENECH AFFILIATE CONSULTANT, AI IN HEALTH Dr Matthew Fenech, MD PhD is an Affiliate Consultant at Future Advocacy, an independent think tank focused on developing policies that maximise the opportunities and minimise the risks of AI. His main interest is in the ethics and practicalities of the use of AI in health and medical research, a field to which he brings his 10 years of experience working as a clinical academic.

REGULATION OF AI IN HEALTHCARE: WHAT SHOULD WE EXPECT? AI holds tremendous promise for healthcare. Technologists frequently talk about ‘disrupting’ healthcare in the same way that technology has disrupted retail, communication, entertainment, and many other spheres of life. We are now seeing a culture clash, between the ‘move fast’ world of technology, and the ‘safety first’ world of medicine. What is the role of regulation in striking the right balance?

What’s on the horizon? What should we, as patients and as clinicians, expect?

THEATRE 9 AI TUESDAY | 14.45

RESEARCH LEAD

Sue Astley leads research in breast radiomics at the University of Manchester.

Her work includes evaluation of novel imaging technologies (CAD, DBT), developing software to detect abnormalities and discover imaging biomarkers, using eye tracking to learn how new imaging systems are best employed, and working closely with radiologists to achieve clinically useful solutions.

DEEP LEARNING FOR BREAST DENSITY ASSESSMENT AND RISK PREDICTION Dr Sue Astley will review the importance of breast density assessment for cancer risk prediction, identifying women for whom mammography is less effective, and assessing the efficacy of risk reducing interventions. Sue will then discuss current methods for density assessment, looking at the strengths and limitations of different approaches. Finally, she will describe density assessment using convolutional neural networks, including a review of the issues associated with developing and validating such approaches.

THEATRE 9 AI WEDNESDAY | 11.45

work. Most importantly, visitors will learn how effective AI can be in improving patient outcomes through incredible analysis of medical imaging.

PAUL BENTLEY ACADEMIC NEUROLOGIST Paul Bentley is an academic neurologist at Imperial College London. One of his main research interests is clinical-translational technologies – with a particular focus on stroke and AI. He is Clinical Lead of the Imperial Neuromuscular Rehabilitation Technology Network, and clinical partner to the Neurotechnology Centre for Doctoral Training at Imperial College.

His current projects include automated CT-brain interpretation, and behavioural monitoring of hospital in-patients.

HOW CAN IMAGINGAI HELP STROKE MANAGEMENT? Clinical decisions in acute stroke are few: to thrombolyse or not? how about thrombectomy?; and, in grave cases, should we surgically decompress?

However, the myriad factors – particularly imaging - which clinicians weigh up to make these decisions are anything but simple. AI methods may represent the optimal way by which multi-stream data can be quantified, rationalized and brought to bear on critical questions of management and outcome.

THEATRE 9 AI WEDNESDAY | 12.30

AI THEATRE

DR SUE ASTLEY

AI THEATRE

AI THEATRE

The new AI theatre will host some of the finest minds working with this emerging technology. Here, visitors will learn how AI will benefit the industry, as well as how regulation and integration across hospital services will

DR PHIL KOCZAN GENERAL PRACTITIONER Dr Phil Koczan has been a GP in Chingford North East London for over 25 years. He is a fellow of the Royal College of General Practitioners and a member of their Health Informatics Group. He is also a Founding Fellow of the Faculty of Clinical Informatics. He has a long interest in Medical informatics and is the CCIO for Digital Interoperability for NHS England (London Region).

ASSESSING THE APPLICATION OF ARTIFICIAL INTELLIGENCE AND ITS USE IN THE NHS This seminar will look at the evolving field of Artificial Intelligence and the potential for use within the NHS. It will particularly focus on how the Clinical Safety can be assessed and the evolving policies and standards that should be used. Dr Phil Koczan’s main interest is how technology can be applied to benefit patient care within the industry, and its application to the NHS.

THEATRE 9 AI WEDNESDAY | 13.15

11

PROFESSOR ZOË WINTERS HONORARY PROFESSOR OF BREAST SURGERY HEAD & NECK

GI

LUNG

BREAST

GU BIRMINGHAM 2019

ONCOLOGY CONVENTION SHOW SPEAKERS Across the focus areas of Head & Neck, Lung, Breast, Gastrointestinal, and Genitourinary, and spread across 3 theatres, the European Oncology Convention will present a world class seminar schedule.

Every seminar is CPD accredited, and will present groundbreaking techniques and research directly from the experts who are working to improve current and future patient outcomes. The international seminar line up will represent respected institutions like University College London and Cancer Research UK Cambridge Centre.

ARIE PARNHAM UROLOGIST & NATIONAL EXPERT IN PENILE SURGERY TUESDAY | THEATRE 11 BREAST GU HEAD & NECK | 14.00 Mr Arie Parnham is a urologist and a national expert in surgery for penile cancer and men’s health issues. He is one of only three surgeons in the North West and North Wales that manages penile cancer in the NHS (all of which are based at The Christie).

He also provides support for men dealing with the consequences of their cancer treatments including the insertion of penile implants for erectile dysfunction.

PENILE SPARING AND MINIMALLY INVASIVE TECHNIQUES FOR PENILE CANCER This seminar will see Arie Parnham, one of three experts on penile cancer in the UK, discussing the most recent literature and advancements in penile cancer surgery. This will be a chance to hear expert insights into treatment of a rare type of cancer as well as getting to grips with surgical advancements.

Zoë Is an Honorary Professor of Breast Surgery at University College London (UCL) and has practiced as a Senior Consultant Oncoplastic Breast Surgeon since 2000. She trained at leading University Hospitals in Johannesburg and Cape Town, South Africa before receiving the Oxford Nuffield Senior Research Fellowship to complete her PhD in Molecular Biology at the University of Oxford, Worcester College with the world leading Medical Oncologist Professor Adrian Harris.

WEDNESDAY | THEATRE 11 BREAST GU HEAD & NECK | 13.15

CAN PATIENTS WITH MULTIPLE BREAST CANCERS IN THE SAME BREAST AVOID MASTECTOMY BY HAVING MULTIPLE LUMPECTOMIES TO ACHIEVE EQUIVALENT RATES OF LOCAL BREAST CANCER RECURRENCE?

In this fascinating seminar, Professor Zoë Winters will discuss if patients with multiple breast cancers in the same breast avoid mastectomy by having multiple lumpectomies to achieve equivalent rates of local breast cancer recurrence.

Alongside this, she will begin to study the protocol for a randomised controlled feasibility trial (UK Miami).

PROFESSOR HISHAM MEHANNA CHAIR OF HEAD AND NECK SURGERY & DIRECTOR Professor Mehanna is the Chair of Head and Neck Surgery, and Director of InHANSE, at the University of Birmingham.

Hisham has a keen interest in clinical and translational research, heading a research team of 20 researchers, and holding over £10 million in research grants. The main areas of his research are Human Papillomavirus-associated head and neck cancer and thyroid cancer.

CLINICAL TRIALS THAT CHANGE PATIENT CARE AND THE LESSONS LEARNT Through examples of studies done in head and neck cancer that have changed patient care, Professor Hisham Mehanna will offer his unrivalled knowledge for visitors to educate themselves with. The current President of the British Association of Head Neck Oncologists, Professor Hisham Mehanna possesses unrivalled knowledge and working insight into this topic.

WEDNESDAY | THEATRE 11 BREAST GU HEAD & NECK | 14.45

RICHARD STEYN CONSULTANT THORACIC SURGEON & DEPUTY MEDICAL DIRECTOR Mr Richard Steyn, is a Consultant Thoracic Surgeon, Deputy Medical Director, University Hospitals Birmingham NHS Foundation Trust and Honorary Associate Professor, University of Warwick and the Chair of the UK Lung Cancer Coalition – the largest UK multi-interest group in lung cancer comprising leading lung cancer experts, senior NHS professionals, all key cancer charities, British Lung Foundation and healthcare companies.

TUESDAY | THEATRE 12 GI, LUNG & IMUNO | 14.00

12

DOUBLING FIVEYEAR UK LUNG CANCER SURVIVAL TO 25% BY 2025 The UK Lung Cancer Coalition (UKLCC) was set up in 2005 with the founding ambition of tackling poor survival outcomes and, specifically to double 5-year survival by 2015, which has now effectively been achieved (in England). The UKLCC is now calling for governments, commissioners and the health care community to re-double efforts and work together to raise 5-year rates to 25% by 2025 across the UK.

JAMES FLANAGAN

DR ANTONIA LAVORATA

SENIOR LECTURER & PRINCIPAL INVESTIGATOR

CLINICAL MEDICAL PHYSICIST

DR SILEIDA OLIVEROS CLINICAL ONCOLOGIST

CLAIRE BARNARD LEAD FOR IMPLEMENTING SBRT & SGRT

SURFACE-GUIDED RADIOTHERAPY AND OPTIMAL BREAST CANCER TREATMENT

Dr. Antonia Lavorato is a clinical medical physicist, involved in clinical physics procedures and quality assurance. Dr Sileida Oliveros is a Clinical Oncologist specialising in breast cancer with 10+ years of experience.

Claire Barnard has over 8 years’ experience in Radiotherapy, improving patient outcomes.

This seminar will describe the use of SGRT to optimise patient positioning for radiotherapy for breast cancer, demonstrating improved accuracy and reliability, increased speed of set-up and better patient experience.

The contribution of this to enabling advanced radiotherapy practice for breast cancer is discussed.

WEDNESDAY | THEATRE 10 RADIATION | 12.30

PROFESSOR FARZIN FARZANEH PROFESSOR OF MOLECULAR MEDICINE & DIRECTOR OF CELL & GENE THERAPY Farzin Farzaneh holds the Chair of Molecular Medicine at King’s College London. He has run a licensed GMP facility at King’s College London, since 2001, for the production of cell and gene therapy based investigational medicinal products. Farzin has extensive collaborations, including research council, charitable and pharmaceutical sponsorships of over £25M. He is appointed by the Commission on Human Medicines, as a member of the Clinical Trials, Biologicals & Vaccines Expert Advisory Group since 2016.

ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS) FOR ACHIEVEMENT OF DEEPER AND LONGER LASTING IMMUNE MEDIATED CANCER REMISSION Cell and gene based therapy of cancer is making major improvements to the treatment of cancer. The development of new strategies for the development of chimeric antigen receptor T cells, genetically modified cancer cell vaccines and therapeutic cancer vaccines for the specific induction of cellular immunity will be described.

TUESDAY | THEATRE 12 GI, LUNG & IMUNO | 13.15

ROLE OF IKKα IN BREAST CANCER In this seminar Joanne Edwards will be discussing how Triple negative breast cancer (TNBC) is the most aggressive subtype of breast carcinoma with limited therapeutic options. IKKα, the main catalytic kinase in the NF-κB non-canonical pathway, may be a novel therapeutic target for treatment of TNBC as elevated levels of phosphorylated IKKα in TNBC specimens is associated with reduced cancer specific survival and treatment of TNBC cell lines with IKKα inhibitors results in reduced cell viability.

JOANNE EDWARDS PROFESSOR OF TRANSLATIONAL CANCER PATHOLOGY Professor Joanne Edwards obtained a BSc in Pharmacology from the University of Glasgow followed by her PhD in Molecular Biology from the University of St Andrews. Her scientific career has included working as a Clinical Scientist in Glasgow Royal Infirmary, followed by a Senior Lecture in the Institute of Cancer Sciences University of Glasgow and more recently in January this year became a Professor of Translational Cancer Pathology.

TUESDAY | THEATRE 11 BREAST GU HEAD & NECK | 12.30

Dr James Flanagan, completed his PhD in Brisbane, Australia, and has pursued postdoctoral work in Cancer Genetics, Epigenetics and Cancer Epigenetics. After receiving the Breast Cancer Campaign Scientific Fellowship he is now a Senior Lecturer at Imperial College London. He was awarded the BACR Translational Researcher Award and is the principal investigator for the OCA funded programme "Risk and Prevention".

EPIGENETIC BIOMARKERS FOR PLATINUM RESPONSE IN OVARIAN CANCER Platinum based chemotherapy is the standard of care for ovarian cancer patients at first line treatment and often at subsequent relapses.

We have identified and validated an epigenetic biomarker detectable in blood DNA that predicts whether a patient should be treated with platinum after relapse. We propose a mechanism by which platinum-adduct DNA repair causes the epigenetic changes and that the genomic and epigenomic location of platinum adducts defines sensitivity.

WEDNESDAY | THEATRE 11 BREAST GU HEAD & NECK | 12.30

KHURUM KHAN RESEARCH-ACTIVE CONSULTANT He gained significant experience in the set-up and running of large multicentre academic and translational studies from the time that he spent in fulltime research, which included working as trial physician for phase II/III studies in early and advanced Colorectal Cancer sponsored by the industry and the Royal Marsden Hospital.

BIOMARKERS OF RESPONSE AND/OR RESISTANCE TO TARGETED THERAPIES IN REFRACTORY MCRC Liquid biopsies capture spatial and temporal heterogeneity underpinning resistance to targeted therapies in various cancers. Dense serial sampling is however needed to predict the time to treatment failure and generate a window of opportunity for intervention.

WEDNESDAY | THEATRE 12 GI, LUNG & IMUNO | 11.00

13

Organised by the Rutherford Cancer Centres, these masterclasses are the best way to consolidate the learning outcomes from the CPD accredited seminars.

Clinicians will be able to practically develop the information from the seminars and ensure that the knowledge is implemented when returning to work. Use this page to plan your masterclass, making sure to book your place in advance to guarantee attendance.

PLEASE BOOK YOUR MASTERCLASS BEFORE THE SHOW AT ONCOLOGYCONVENTION.COM

TUESDAY ADDRESSING CURRENT CHALLENGES IN RADIATION ONCOLOGY SOLUTIONS TUESDAY | 11.00

EMBRACING EVOLVING TECHNOLOGY IN CANCER CARE TUESDAY | 12.00

USING RESEARCH TO DRIVE ONCOLOGY ADVANCEMENT TUESDAY | 14.00

PROTON THERAPY AND ITS BENEFITS FOR SELECTED INDICATIONS TUESDAY | 15.00

Proton Partners International is at the vanguard of advancing cancer care, building a series of oncology centres across the UK known as the Rutherford Cancer Centres. Working with partners including IBA and Philips Healthcare, the Rutherford Cancer Centres are at the forefront of providing innovative cancer care with proton beam therapy, radiotherapy, chemotherapy, immunotherapy, imaging services and supportive care.

WEDNESDAY PROTON THERAPY: TREATMENT WORKFLOW AND THE DIFFERENCE WITH CONVENTIONAL RADIOTHERAPY WEDNESDAY | 11.00

THE TRANSITION TO PROTON THERAPY AND TREATING THE FIRST PATIENT IN THE UK WEDNESDAY | 12.00

DELIVERING PATIENT EXPERIENCE ALONGSIDE CLINICAL EXCELLENCE WEDNESDAY | 13.00

UNDERSTANDING THE CHANGING LANDSCAPE OF CANCER RESEARCH WEDNESDAY | 14.00

PHOTOS COURTESY OF RUTHERFORD CANCER CENTRES

MASTERCLASSES 14

TRANSFORMING CANCER CARE

17 & 18

MARCH

2020

NEC BIRMINGHAM

INTRODUCING

MEDIWEEK THE UK’S LARGEST HEALTHCARE EVENT HEAD & NECK HEAD & NECK

GI

LUNG

BREAST

GI

LUNG

BREAST

GU BIRMINGHAM 2019

SURGERY SURGERY

GU BIRMINGHAM 2019

AI&ML CONVENTION

FOR CONNECTED & ASSISTED LIVING

VISIT WWW.MEDIWEEK.CO.UK FOR MORE INFORMATION

Join free at

Join Radiology and Oncology Case Discussion Groups on MedShr! • Discover and discuss clinical cases in imaging and cancer • Post scans, images and cases to reflect on your practice • GMC and HIPAA compliant case discussion network • Connect with over 750,000 verified doctors and HCP

Radiology: medshr.it/MIC2019 Oncology: medshr.it/EOC2019

KEYNOTE THEATRE 1 TUESDAY

KEYNOTE THEATRE 1 IMAGING | TUESDAY

Professor Feng Wu, University of Oxford Focused Ultrasound Therapy for Tumours: Current Status and Future Prospective

11.00 - 11.30

Ernesto A. Cerdena, PhD, AtlantiCare Regional Medical Center Challenges and Success in Adopting Clinical Decision Support Mechanism In Diagnostic Imaging

11.45 - 12.15

Laura Allington, University College London Hospitals NHS Foundation Trust Operational Challenges of Planning a New NHS High Energy Proton Service

12.30 - 13.00

Terry Jones, University of California, Davis u EXPLORER: The World’s First Total-Body PET Scanner

13.15 - 13.45

Dr med. Christoph Juli FRCR, Medizinisches Diagnose-Zentrum Uster Compressed SENSE Cardiac Magnetic Resonance (CMR) Imaging With the 1.5T Ambition X BlueSeal Magnet

14.00 - 14.30

Dr Sarah Brüningk, The Institute of Cancer Research The Role of Ultrasound Therapy in Cancer Treatments

14.45 - 15.15

15.30 - 16.00 Sue Edyvean, Public Health England National Diagnostic Reference Levels for Patient Radiation Dose – Current Status, Future Plans, and How to Contribute

KEYNOTE THEATRE 1 WEDNESDAY

KEYNOTE THEATRE 1 IMAGING | WEDNESDAY

16

SPONSORED BY

SPONSORED BY

Dr med. Christoph Juli FRCR, Medizinisches Diagnose-Zentrum Uster Compressed SENSE Cardiac magnetic resonance (CMR) Imaging with the 1.5T Ambition X BlueSeal Magnet

11.00 - 11.30

Dr Serguei Semenov, EMTensor GmbH Electromagnetic Tomography for Brain Imaging

11.45 - 12.15

Prof Iris Quasar Grunwald, Anglia Ruskin University, Chelmsford, Southend University Hospital The UK’s 1st Mobile Stroke Unit – Is This the Future?

12.30 - 13.00

Prof Karen J Kirkby, The University of Manchester and The Christie NHS Foundation Trust Proton Beam Therapy in Manchester: The Story So Far

13.15 - 13.45

Rachael Hinchliffe, University Hospitals Birmingham NHS Trust (HGS) sites Plain Film Service Challenges? - How Do Digital lmaging Systems Help?

Moira Crotty, NHS Digital IT and Informatics Toolkit for Imaging Networks

14.00 - 14.30

14.45 - 15.15

* Content and speakers are subject to change. The digital show guide and seminar timetable will be updated online prior to the show, so please check imagingconvention.com for the latest information.

11.00 - 11.30 Dr Matthew Prime, Roche Diagnostics Information Solutions Personalized Healthcare: Leveraging Data to Improve Patient Care Through Clinical Decision Support in Oncology

Dr Farzana Rahman, Hexarad and University College London Hospitals The Ethics of AI in Healthcare

11.45 - 12.15

Dr Anthony Holmes, Holmes Consulting Bridging the Gap: How Good Ideas Become Great Products

12.30 - 13.00

Ozan Oktay, Imperial College London Neural Networks in Medical Imaging: Towards More Reliable and Automated Clinical Analysis

13.15 - 13.45

Dr Hugh Harvey, Kheiron Medical Technologies Deep Learning in Breast Cancer Screening

14.00 - 14.30

Dr Matthew Fenech, Future Advocacy Regulation of AI in Healthcare: What Should We Expect?

14.45 - 15.15

Dr Mark Halling-Brown, Royal Surrey County Hospital Practicalities of Creating Medical Image Research Databases for AI

15.30 - 16.00

Piotr Giedziun & Michal Krason, CancerCenter.AI Deep Learning in Oncology Diagnostics

14.45 - 15.15

THEATRE 9 TUESDAY

THEATRE 9 AI & MACHINE LEARNING | TUESDAY

Prof Paul Leeson, University of Oxford Is AI About to Revolutionise Cardiovascular Ultrasound Diagnostics?

11.00 - 11.30

Dr Sue Astley, University of Manchester Deep Learning for Breast Density Assessment and Risk Prediction

11.45 - 12.15

Paul Bentley, Imperial College London How Can Imaging-AI help Stroke Management?

12.30 - 13.00

Dr Phil Koczan, NHS England Assessing the Application of Artificial Intelligence and its Use in the NHS

13.15 - 13.45

Simon Walker-Samuel, UCL Using Medical Imaging With Machine Learning to Develop Efficient Tools for Diagnosing Cancer

14.00 - 14.30

Senthil Periaswamy, iCAD Inc. How AI Can Improve Diagnostic Performance and Reduce Reading Time in Breast Tomosynthesis

14.45 - 15.15

* Content and speakers are subject to change. The digital show guide and seminar timetable will be updated online prior to the show, so please check imagingconvention.com for the latest information.

THEATRE 9 WEDNESDAY

THEATRE 9 AI & MACHINE LEARNING | WEDNESDAY

17

THEATRE 10 WEDNESDAY

THEATRE 10 TUESDAY

THEATRE 10 RADIATION | TUESDAY

18

Dr Nathan Hill, Medinformatics Ltd Electronic Medical Records – Have They Lived up to Expectations?

11.00 - 11.30

Kate Casey, Leeds Gamma Knife Icon Leksell Gamma Knife Stereotactic Radiosurgery

11.45 - 12.15

Dr Anna ME Bruynzeel, Amsterdam UMC (formerly VUmc) MR Guided Adaptive Radiation Therapy; Three Years of Clinical Experience at VUmc

12.30 - 13.00

Odette Woods, Cancer Hopeline Empowering Cancer Patients to Optimal Treatment Outcomes and Prognosis

13.15 - 13.45

Dr Zayad Ratansi, O3 Health Ltd Hyperbarics Within Oncology

14.00 - 14.30

Piotr Giedziun & Michal Krason, CancerCenter.AI Deep Learning in Oncology Diagnostics

14.45 - 15.15

THEATRE 10 RADIATION | WEDNESDAY Professor Sun Myint, Clatterbridge Cancer Centre (Private Clinic) Rectal Cancer- Do Patients Have a Choice?

11.00 - 11.30

Dr Keith Tsui, Medopad Remote Patient Monitoring: Bringing the Hospital into the Home

11.45 - 12.15

Dr Sileida Oliveros, Dr Antonia Lavorat & Claire Barnard, GenesisCare UK Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment

12.30 - 13.00

Luca Boldrini, Università Cattolica del Sacro Cuore, Roma, Italia Radiomics Applications Rectal Cancer: The MRIdian Perspective

13.15 - 13.45

Kate Casey, Leeds Gamma Knife Icon Leksell Gamma Knife Stereotactic Radiosurgery

14.00 - 14.30

Bertil RR Persson, Scandinavian ChemoTech AB Dynamic-ElectroEnhanced Chemotherapy Brings Relief to Patients with Large Tumour Burden

14.45 - 15.15

* Content and speakers are subject to change. The digital show guide and seminar timetable will be updated online prior to the show, so please check oncologyconvention.com for the latest information.

Christopher Curtis, The Swallows Head & Neck Cancer Charity From Cancer to the Palace in 6 years

11.00 - 11.30

Dr Richter-Heine, Praxisgemeinschaft im Camparihaus Benefits of Supporting Medical Garments in Breast Surgery

11.45 - 12.15

Joanne Edwards, University of Glasgow Role of IKK alpha in Breast Cancer

12.30 - 13.00

13.15 - 13.45 Hamed Javan MD, Jewish General Hospital Systemic Cancer Therapy: Pancreatic and Colorectal Cancer – Pre-operative FOLFIRINOX in Pancreatic Cancer

Arie Parnham, The Christie NHS Foundation Trust, Manchester Penile Sparing and Minimally Invasive Techniques for Penile Cancer

14.00 - 14.30

Professor Sun Myint, Clatterbridge Cancer Centre (Private Clinic) Rectal Cancer - Do Patients have a Choice?

14.45 - 15.15

THEATRE 11 TUESDAY

THEATRE 11 BREAST GU HEAD & NECK | TUESDAY

Jamie Rae, Throat Cancer Foundation The Throat Cancer Foundation; How We Changed a Government’s Mind

11.00 - 11.30

11.45 - 12.15 Hamed Javan MD, Jewish General Hospital Systemic Cancer Therapy: Pancreatic and Colorectal Cancer – Pre-operative FOLFIRINOX in Pancreatic Cancer

James Flanagan, Imperial College London Epigenetic Biomarkers for Platinum Response in Ovarian Cancer

12.30 - 13.00

Professor Zoë Winters, University College London Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy

by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence?

13.15 - 13.45

Sally Hayes, Maggie’s Centres Maggie’s programme of emotional support

14.00 - 14.30

Professor Hisham Mehanna, InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham Clinical Trials That Change Patient Care and the Lessons Learnt

14.45 - 15.15

* Content and speakers are subject to change. The digital show guide and seminar timetable will be updated online prior to the show, so please check oncologyconvention.com for the latest information.

THEATRE 11 WEDNESDAY

THEATRE 11 BREAST GU HEAD & NECK | WEDNESDAY

19

THEATRE 12 TUESDAY

THEATRE 12 GI, LUNG & IMUNO | TUESDAY Stefan Schuster, Datar Cancer Genetics Limited Clinical Utility of Liquid Biopsy in Brain Tumors

11.00 - 11.30

Corina van den Hurk, Paxman Coolers LtdNetherlands Comprehensive Cancer Organisation Hair Loss Through Chemotherapy is Not Inevitable!

11.45 - 12.15

Sally Hayes, Maggie’s Centres Maggie’s Programme of Emotional Support

12.30 - 13.00

Professor Farzin Farzaneh, King’s College London Advanced Therapy Medicinal Products (ATMPs) for Achievement of Deeper and Longer Lasting Immune Mediated Cancer Remission

13.15 - 13.45

Mr Richard Steyn, UK Lung Cancer Coalition / University Hospitals Birmingham NHS Foundation Trust Doubling Five-Year UK Lung Cancer Survival to 25% by 2025

14.00 - 14.30

Dr Omar Milhem, Pharma Medico Ltd Clinical Management of Proteoglycan Follicular Atrophy in Female Hair Loss

14.45 - 15.15

Odette Dr OmarWoods, Milhem, Cancer Pharma Hopeline Medico Ltd Clinical Management Empowering Cancer Patients of Proteoglycan to Optimal Follicular Treatment Atrophy Outcomes in Female and Prognosis Hair Loss

14.45 - 16.00 15.30 15.15

THEATRE 12 WEDNESDAY

THEATRE 12 GI, LUNG & IMUNO | WEDNESDAY

20

Khurum Khan, Royal Marsden NHS Foundation Trust Biomarkers of Response and/or Resistance to Targeted Therapies in Refractory mCRC

11.00 - 11.30

Christopher Curtis, The Swallows Head & Neck Cancer Charity From Cancer to the Palace in 6 years

11.45 - 12.15

Andras Szasz, St. Istvan University Modulated Electrohyperthermia (mEHT) for Advanced Malignant Tumours

12.30 - 13.00

Jocelyn Harding CEB DipDH, Oralieve UK The Importance of Mouth Care for Cancer Patients

13.15 - 13.45

Martyn Kennedy, Leeds Teaching Hospitals NHS Trust The Yorkshire Lung Screening Trial (YLST)

14.00 - 14.30

* Content and speakers are subject to change. The digital show guide and seminar timetable will be updated online prior to the show, so please check oncologyconvention.com for the latest information.

Andy Rogers, Nottingham University Hospitals NHS Trust Integrating Interventional Procedure Data to Improve Clinician Feedback – New Technology Gains Maturity

11.00 - 11.30

Prof Alan Perkins, University of Nottingham Hybrid Optical-Gamma Camera Imaging in Nuclear Medicine

11.45 - 12.15

Dr Heather Williams, The Christie State of the Art Positron Emission Tomography

12.30 - 13.00

Dr Dan Rose, Everlight Radiology Radiology Service Delivery in 2019 - Riding the Storm

13.15 - 13.45

Cheerag Shirodaria, Caristo Diagnostics Fat Attenuation Index: A Game Changer in Coronary Artery Risk Assessment?

14.00 - 14.30

David Gibbins, Micrima Ltd Radio-wave Breast Imaging a New Technology

14.45 - 15.15

Carlos Schorlemmer, Telemedician Clinic Innovative E-training Platforms: Key for Quality Diagnostic Imaging Reporting

15.30 - 16.00

THEATRE 13 TUESDAY

THEATRE 13 IMAGING | TUESDAY

Prof Sandro Olivo, UCL Phase Contrast Imaging: Giving X-rays Soft Tissue Sensitivity

11.00 - 11.30

Dr Dan West, Everlight Radiology Professional and Social Pros and Cons of Life as a Full-time, Overseas Teleradiologist

11.45 - 12.15

Dr Fred Ushakov, University College London Hospital and London School of Ultrasound Spina bifida: Early Diagnosis at 11-13 Weeks of Pregnancy

12.30 - 13.00

Gary Royle, UCL Novel Imaging and Sensor Systems for Radiotherapy

13.15 - 13.45

Dr Richard Sidebottom, Thirlestaine Breast Centre, Cheltenham NHS and Royal Marsden Hospital AI Basics and Application in Mammography

14.00 - 14.30

Sarah-May Gould, King’s College London and Guy’s and St Thomas’ PET Centre A Review of Attenuation Correction in Positron Emission Tomography

14.45 - 15.15

* Content and speakers are subject to change. The digital show guide and seminar timetable will be updated online prior to the show, so please check imagingconvention.com for the latest information.

THEATRE 13 WEDNESDAY

THEATRE 13 IMAGING | WEDNESDAY

21

THEATRE 14 TUESDAY

THEATRE 14 IMAGING | TUESDAY Larry Sitka, Vital Images Inc Enterprise Imaging, the First Step to a Learning Health System

11.00 - 11.30

Dr Andrew Bagshaw, University of Birmingham Multimodal Neuroimaging: Methods and Applications of Combined EEG-fMRI

11.45 - 12.15

Wai Lup Wong, Mount Vernon Hospital PET CT in the Surveillance of People with Head and Neck Cancer

12.30 - 13.00

Peter Ross, Birkbeck University of London Improving Quality of Diagnostic PET-CT Reporting: Factors Influencing Doctors’ Performance

13.15 - 13.45

Iris Asllani, Brighton and Sussex Medical School Multimodal Functional Imaging of the Diseased Brain

14.00 - 14.30

David Omiyi, Everything Radiography Artificial Intelligence - The Future of Medical Imaging

14.45 - 15.15

Matthew Gardner, RRPPS, University Hospitals Birmingham NHS Foundation Trust Patient Dosimetry Audit for Nuclear Medicine and Radiotherapy Planning CT

15.30 - 16.00

THEATRE 14 WEDNESDAY

THEATRE 14 IMAGING | WEDNESDAY

22

Laura Shell, University Hospital Birmingham (HGS) The Impact of Computerised Tomography Standardisation in the UK

11.00 - 11.30

Dorothee Auer, University of Nottingham Novel MRI Biomarkers in Parkinson’s

11.45 - 12.15

Professor James O’Connor, University of Manchester Developing a New MRI Method of Tracking Hypoxia in Cancer

12.30 - 13.00

Dr Simeon Nill, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust MR Image-guided Radiotherapy Treatment on the MR-Linac

13.15 - 13.45

Peter Ross, Birkbeck University of London Improving Quality of Diagnostic PET-CT Reporting: Factors Influencing Doctors’ Performance

14.00 - 14.30

* Content and speakers are subject to change. The digital show guide and seminar timetable will be updated online prior to the show, so please check imagingconvention.com for the latest information.

EXHIBITOR LISTINGS 2019 4ways Healthcare Stand Number 836 4ways is a multi-accredited provider of remote radiology reporting services. We provide a highly flexible and responsive tele-radiology service to meet your needs. We operate 24/7/365 and work with many Trusts across the UK, offering a high quality industry compliant service.

01442 260 322 4waysdiagnostics.co.uk Agfa HealthCare UK Limited Stand Number 338 More than a century of imaging experience enables Agfa to deliver diagnostic imaging solutions that set standards in productivity, safety, clinical value, and cost effectiveness.

0044 844 892 2004 www.agfa.com Amoena Stand Number 480 Established in 1975, Amoena is the world`s leading breast-care brand and was the first company to introduce a silicone breast prosthesis. As the industry pioneer, Amoena combines technology with supreme comfort, offering an extensive range of lingerie, swimwear and breast symmetry products. www.amoena.com/uk-en APC Cardiovascular Ltd Stand Number 336 APC Cardiovascular helping build a better radiation safety culture through measurement, management and education. RaySafe i3; Xenolite Strata bilayer apron; RADPAD scatter shields; gloves; glasses; Kenex. Come talk through new regs, book on-site training, enter the draw for a free Apron.

01606 331 119 www.xrayaprons.co.uk Bracco UK Stand Number 135 Bracco is a multinational group, active in the healthcare sector with a total of 3,100 employees operating in more than 100 countries around the world. Over the years Bracco has intensified its commitment to innovative specialised research in imaging agents for diagnostic medicine. Visit stand 135.

01628 851500 www.imaging.bracco.com/gb-en Breast Cancer Now Stand Number 488 Breast Cancer Now is the UK`s largest breast cancer charity. Our world class research is focused entirely on breast cancer and supports 380 of the worlds brightest researchers across the UK and Ireland. Our ambition is that by 2050 everyone who develops breast cancer will live - and live well.

0333 20 70 300 www.breastcancernow.org/breast-cancerhealthcare-professional-contact-form?utm_ source=EU-oncology-convention&utm_ medium=website&utm_campaign=hcp-signups CAE Healthcare Stand Number 340 CAE Healthcare is a training partner of choice for hospitals, clinicians, educational institutions and military organizations worldwide. Visit the CAE Healthcare booth to learn about our CAE Vimedix platform, which offers training for point-of-care ultrasound as well as echocardiography and Ob/Gyn. 01865 840334 www.caehealthcare.com

Cancer Center Stand Number 954 Using Deep Learning (DL) and Machine Learning (ML) platforms, we have developed specialized algorithmic solutions to analyze medical images for oncology and radiology for faster and better than human accuracy.

0048 694 233 234 www.cancercenter.ai Caragen Ltd Stand Number 492 Visit our stand to see our range of Oncology Closed System Transfer Devices for both Isolator compounding and provision of a fully closed range for Bolus and IV Infusions on the Oncology wards.

We will also display our full range of protective PPE systems for both Pharmacy and Ward infusions.

00353 1 568 8960 www.caragen.com CERCA Stand Number 294 CERCA is a unique and secure mobile application that uses private member profiles to recommend highly relevant new connections based on shared interests and goals. CERCA supercharges your network-building with pinpoint accuracy while saving you energy. CERCA finds people that move you . . . forward.

08034 150 509 www.cerca.io Clatterbridge Private Clinic Stand Number 266 Clatterbridge Private Clinic offers an extensive range of innovative and specialist treatments. Clatterbridge Private Clinic was first provider of Papillion - a pioneering non-surgical treatment for early stage rectal cancer and is the unique provider of Proton therapy to treat melanoma of the eye.

0151 556 5391 www.clatterbridgeprivate.co.uk ClearTrace Stand Number 448 ClearTrace are specialists in infection control cleaning and auditing. We are the largest supplier of infection control cleaning services to the private MRI, CT and CAT industry covering all the UK and a fast-growing presence in the deep cleaning of medical surgeries.

01524 220 225 www.cleartrace.co.uk Combinostics Stand Number 846 Combinostics` cNeuro provides clinical decision support in neurodegenerative diseases. It uses machine learning to compare the patient`s data to data from previously diagnosed cases and the system presents information about disease etiology and predictive information about disease progression.

0046 730 699 057 www.cneuro.com Datar Cancer Genetics Stand Number 282 Sustained Commitment And An Unapologetic Determination To Succeed Against Cancer.

0091 2536 604 828 www.datarpgx.com Derwent Healthcare Ltd Stand Number 667 Derwent Healthcare, UK suppliers for Bionic Therapy Chairs. We are a main supplier to NHS Chemotherapy Units & also a preferred supplier to Macmillan Cancer Care, Spire Healthcare, Genesis Cancer Care and Nova. Bionic are launching the ComfortLine2 a new standard in patient comfort & safety.

01661 886 169 www.derwenthealthcare.com

Diagnostic Healthcare Ltd Stand Number 436 DHC is one of the largest providers of diagnostic imaging and reporting services in the UK: MRI, CT, Ultrasound and DEXAs, performing 180,000+ scans annually. Offering additional capacity and rapid access, improving waiting times through our modern, mobile MRI and CT scanners.

0161 929 5679 www.dhc.uk.com EIZO Limited Stand Number 642 EIZO`s complete spectrum of medical monitors deliver exceptionally accurate and stable images the world over, providing monitor solutions for all areas of Healthcare Imaging. Whether you need colour, greyscale or a monitor to display both; Primary Diagnosis or Clinical Review, EIZO has the solution.

01344 371 480 www.eizo.co.uk EMS Healthcare Stand Number 260 EMS Healthcare own, operate and manage one of the UK`s most extensive fleet of flexible mobile medical units. Our vital, tailor-made facilities can be configured to suit a range of clinical environments, such as supporting clinical research, screening services and providing mobile infusion services.

0151 350 1590 www.ems-healthcare.com EMTensor GmbH Stand Number 437 Our unique and patented medical imaging device is the smallest among all available brain tomographic imaging technologies, EMTensor BrainScanner is compact and maneuverable. It can be brought to the stroke patient, eliminating the need for intrahospital transportation of unstable patients.

0043 1 89 066 12 www.emtensor.com EndoSoft Stand Number 370 EndoVault is a specialty specific oncology EHR designed with the help of world renowned oncologist for Medical, Surgical, Radiation, Breast, Gastroenterology, Hematology, Lung, Head & Neck, Neurology, Gynecology, Urology & Dermatology.

0044 116 3800518 www.endosoft.com Everlight Radiology Stand Number 554 Everlight is a global teleradiology company providing urgent and routine radiology reporting services to over 200 hospitals across the United Kingdom, Australia and New Zealand. Our team of 300+ NHS experienced consultant radiologists provide reliable, quality reporting 24/7 365 days of the year.

0300 400 1111 www.everlightradiology.com Fairford Medical Limited Stand Number 643 Fairford Medical is the fastest growing UK provider of relocatable and mobile MRI and CT scanning solutions and have developed the compact and affordable CT SCANBOX to meet demand for short or long term scanning requirements.

0207 317 3000 www.fairfordmedical.com Flen Health Ltd Stand Number 872 GenesisCare Stand Number 380 www.genesiscare.co.uk

23

iCAD, Inc. Stand Number 840 iCAD is a market leader in advanced breast cancer detection solutions built on artificial intelligence, that enable radiologists to find cancers earlier while improving reading workflow. The Breast Health Solutions suite delivers powerful detection and workflow solutions for 2D and 3D mammography.

001 603 882 5200 www.icadmed.com

Maggie’s Stand Number 290 Maggie`s helps anyone affected by cancer. At Maggie`s you can talk to and get support from a range of professionals. Our 21 Centres are staffed

by Cancer Support Specialists, Benefits Advisors, Nutritionists, therapists and Psychologists, all providing support in whichever way best suits you.

0044 (0)20 72386 3561 www.maggiescentres.org

Noras MRI products GmbH Stand Number 844 Noras can look back on more than 30 years of experience in the development and sale of MRT coils and accessories. Our product portfolio includes MR solutions for breast biopsy, neurosurgery, prostate intervention, orthopedics, pediatrics and dental imaging.

0049 931 299 270 www.noras.de

ICU UK Medical Ltd Stand Number 272 ICU Medical connects patients and caregivers through lifesaving and life-enhancing medical devices: Infusion devices - Plum 360 & Sapphire, dose error reduction software - MedNet, infusion sets, needlefree connectors, IV catheters and closed system transfer devices for hazardous IV drugs.

0203 357 9400 www.icumed.com

MEDICA Group Stand Number 729 MEDICA Group is the UK`s largest teleradiology provider, delivering first class teleradiology reporting services to the NHS and independent healthcare providers through its growing network of over 350 UK based Radiologists.

033 33 111 222 www.medicagroup.co.uk

O3 Health Ltd Stand Number 984 O3 HEALTH is the UK’s leading supplier of Portable Hyperbaric Chambers. Used for Sporting , Cosmetic and Medical applications.

07403 998 579 www.o3health.co.uk

InHealth Group Stand Number 842 InHealth is the UK`s largest specialist provider of diagnostic and healthcare solutions. Our mission is to make healthcare better and we do this by working with hospitals and commissioners across the NHS and independent sector.

01494 560000 www.inhealthgroup.com

MedInfomatics Stand Number 852 iNOTZ, optimised for radiation oncology, has multiple modules through which both the patient, nurses and the consultant interact via sets of on-screen menus to create clear, accurate and concise clinical notes delivered in a consistent format. Following USA success, 2019 marks the launch for the UK. 029 20193494 www.medinfomatics.co.uk

Interact Medical Stand Number 828 Interact Medical are an award winning, National Framework approved medical recruitment agency, specialising in the placement of Locum & Permanent Doctors, AHP’s and Nurses within the NHS and Private Sector.

01908 357900 www.interactmedical.co.uk

Medopad Stand Number 264 Medopad`s remote monitoring solution enables NHS clinical teams in rare and chronic disease to track patient progress outside hospital, transform care pathways and improve standards of care. Our app provides a secure platform for patients to share tailored health data with their clinician. www.medopad.com

JCA Medical Seminar Stand Number 559 Here at JCA Medical Seminars we understand the increasing importance and value of CPD to appraisal, accreditation and revalidation. Which is why we have chosen to specialise solely in high quality, interactive, hands on imaging seminars created by and for Radiologists and associated specialisms.

01485 210 687 www.jcaseminars.com

Merit Medical Stand Number 581 Founded in 1987, Merit Medical Systems, Inc. is a worldwide company engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in radiology, oncology, cardiology and endoscopy. www.merit.com/

Jusha Displays Stand Number 246 LANDAUER Stand Number 558 LANDAUER, RaySafe and Fluke Biomedical are a leading global provider of healthcare technologies dedicated to protecting lives.` LANDAUER enables healthcare professionals to measure radiation.

RaySafe provides technologies for measuring real-time radiation in healthcare and industrial applications.

1865 373008 www.landauer.co.uk/ LBN Medical Stand Number 550 LBN Medical is a world leading reseller of used and refurbished medical Imaging equipment. Our large facility holds ultrasound, MRI, and CT scanners, X-ray equipment, and accessories. We have more than 15 years of experience and our international team provides optimal solutions for all customers.

0045 96 886 500 www.lbnmedical.com

24

Mermaid Medical Ltd Stand Number 363 Mermaid Medical welcomes you to stand 363. We are the UK distributor of CIVCO who manufacture Needle Guides, Covers and Brachytherapy Grids. Also: The CO2mmander a Co2 delivery system for imaging, Biopsy devices, Breast markers/localisation wires and a Mechanical Thrombectomy device.

01704 560 493 www.mermaidmedical.com Micrima Stand Number 261 Micrima has developed a breast imaging system that uses radio-wave technology. This system has no ionising radiation, no breast compression and is proving excellent in dense tissue. This means it can be used frequently from a young age in the battle against breast cancer.

01172 510 032 www.micrima.com/ MRS Systems, Inc. Stand Number 440 MRS Systems, Inc. tracks and reports on breast and lung cancer screening and imaging reports, among others. We also create patient and referring physician portals to support a paperless and environmentally friendly workflow.

08002 534 827 www.mrssys.com

Oncotherm Kft. Stand Number 362 Oncothermia is based on the classical method of Hyperthermia, one of the oldest cancer treatment methods. The method is used in more than 30 countries worldwide with over 400 devices. We have numerous clinical publications and patents. The number of treatments are 200.000+ yearly.

003623 555 510 www.oncotherm.com Oralieve UK Stand Number 280 A range of products providing effective and lasting relief from the symptoms of dry mouth. Can be prescribed to help alleviate dry mouth associated with oncology treatment.

01582 729918 www.oralieve.co.uk P14 Medical Ltd Stand Number 534 Platform-14 are leaders in pain management devices which are used across the NHS. Our stand has the latest Neuromodulation devices on show which greatly aid treatment of chronic pain and rehabilitation. We are partners with INFAB Corp, world leaders in radiation protection garments.

0845 257 1014 www.platform-14.com Paxman Stand Number 274 Paxman is the leading global expert in preventing Chemotherapy-induced Alopecia. Paxman know that CIA is often devastating. Patient care is at our heart: our goal is to ensure everyone has the opportunity to maintain normality, retain their hair and self confidence.

0044 (0)1484 349444 www.paxmanscalpcooling.com Pharma Medico Ltd Stand Number 286 Pharma Medico is a global organisation founded on a strong Scandinavian tradition of research and scientific documentation, which means that all products in our portfolio are researched, developed and produced under pharmaceutical protocols and marketed in the form of non-prescription pharmaceutical.

01782 793050 www.pharmamedico.com Philips Stand Number 630 Philips is a leading health technology company focused on improving people`s health and enabling better outcomes across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Come and see us on stand 630 to see a showcase of our latest innovations.

01483 910039 www.philips.co.uk/healthcare/medicalspecialties/radiology

Planmed Stand Number 134 Ratti Stand Number 284 Ratti, since 1945, is one of the most important leading producers of fabrics for womenswear, furnishing and accessories (scarves and ties) in silk and other natural high-quality fibres.

0039 3346 742 679 www.ratti.it Raysafe Stand Number 558 RaySafe and LANDAUER focus on measuring and reducing radiation exposure for healthcare professionals. RaySafe provides technologies for measuring real-time radiation in healthcare and industrial applications. LANDAUER enables healthcare professionals to measure radiation exposure. www.raysafe.com Roche Diagnostics Information Solutions Stand Number 856 A global pioneer in healthcare, Roche is focused on advancing science to improve lives. With more than 100 years of expertise in medicine and biology, Roche is uniquely positioned to leverage data, analytics and software to drive personalized healthcare. www.navify.com Rothband Stand Number 542 Pioneering in X-Ray Protection since 1911.

01706 830 086 www.rothband.com Rutherford Cancer Centres Stand Number 570 The Rutherford Cancer Centres are at the forefront of providing innovative cancer care, providing allencompassing cancer services that offer world-class proton beam therapy, along with traditional services, including diagnostics, chemotherapy, immunotherapy, radiotherapy, and holistic therapy.

01633 740 005 www.therutherford.co.uk Samsung NeuroLogica Stand Number 238 NeuroLogica, the healthcare subsidiary of Samsung Electronics, develops and manufactures innovative imaging technologies and is committed to delivering fast, easy, and accurate diagnostic solutions to healthcare providers. We are the global headquarters and manufacturer of computed tomography (CT).

978-564-8500 www.neurologica.com/ Sky Factory Stand Number 538 The Sky Factory designs and manufactures the only award-winning, research-verified virtual skylights in the world.

06414 721 747 www.skyfactory.com Soliton IT Stand Number 530 Soliton IT is a UK-based Radiology solutions company who designs, supplies and deploys Radiology Information Systems (RIS), Radiology Reporting Sharing networks and VR applications into many NHS Trusts and healthcare centres.

0208 123 7000 www.solitonit.com Sterylab S.R.L. Stand Number 566

Telemedicine Clinic Stand Number 257 We are Europe’s Leading Sub-Specialty Radiology Centre. This year, our team of more than 180 highlyspecialised radiologists will report more than a half of a million cases, making a significant positive impact in the life of hospital staff and patients.

0034 93 550 07 50 www.telemedicineclinic.com The Leeds Gamma Knife Centre Stand Number 680 Gamma Knife Icon Radiosurgery enables flexibility, precision and increased clinical versatility with the ability to choose the level of immobilisation between fixed frame or mask with CBCT & intra-fraction monitoring for the treatment of intracranial lesions.

0113 206 7751 www.leedsgammaknifecentre.co.uk The Royal Marsden NHS Foundation Trust Stand Number 490 At The Royal Marsden, we deal with cancer every day so we understand how valuable life is. And when people entrust their lives to us, they have the right to demand the very best. The Royal Marsden experienced and dedicated event management Team organises world-class medical events and study days.

02078 082 924 www.royalmarsden.nhs.uk/studydays The Swallows Head & Neck Cancer Support Charity Stand Number 484 The Swallows are the patient & carers Head and Neck Cancer Support Charity based in the UK, yet supporting people around the globe. The Charity offers a 24/7 support line and monthly meetings for patients and carers alike.

0044 1253 428 940 www.theswallows.org.uk Throat Cancer Foundation Stand Number 741 We are a foundation who provide support, advice and information to people and their loved ones who are affected by cancers of the head, mouth and neck.

We also support scientific and medical research into better treatment and care processes for those with throat cancers.

0203 4754 065 www.throatcancerfoundation.org Trycare Stand Number 270 Trycare introduce the unique Dr Kim Shadowless Light. A headlight system which can be used with existing surgical magnification loupes or prescription glasses enabling the user to work with much greater visibility. Dr Kim is very light-weight & comfortable so can be worn for long periods of time.

01274 885544 www.trycare.co.uk/dr-kim

Varian Medical Systems Stand Number 781 Varian the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology.

0041.41.749.8844 www.varian.com ViewRay, Inc. Stand Number 980 ViewRay, Inc. designs, manufactures and markets the MRIdian® Linac. Built upon a proprietary highdefinition MR imaging system MRIdian addresses the unique challenges and clinical workflow for advanced radiation therapy.

001 650 252 0920 www.viewray.com Vital Images Europe Stand Number 255 Vital, a Canon Group company, has a legacy of leadership in healthcare imaging using smart algorithms and techniques of innovation spanning 30 years. As the premier provider of an enterprise imaging (EI) solution focused on interoperability, seamlessly connects disparate PACS and other data sources.

0047 95135 214 www.vitalimages.com Water-Jel Europe LLP Stand Number 684 Water-Jel Technologies International For more than 25 years Water-Jel as the world market leader have been offering their tried and trusted Pre-Hospital burn care products for the Pre-Hospital treatment of burn injury victims.

01992 583222 www.waterjel.com Xograph Healthcare Stand Number 725 Xograph Healthcare extends a warm welcome to you at the Medical Imaging Convention. Xograph is a leading independent provider of diagnostic X-ray imaging systems with a product portfolio that includes Digital radiography, fluoroscopy, surgical, mobile, dental and rental imaging equipment solutions.

01453 820 320 www.xograph.com Zendra Health Stand Number 866

TTM Healthcare Stand Number 250 TTM Healthcare is a pioneering recruiter of domestic and international health and care professionals. We work with clients across the UK, Ireland and Middle East to deliver award-winning, multidisciplinary staffing solutions.

020 3582 6053 www.ttmhealthcare.co.uk TXM Healthcare Stand Number 242 TXM Healthcare are a specialist healthcare recruitment agency covering the UK and internationally, offering unique locum and permanent positions within the NHS and private sector. If you are a Doctor, Nurse or AHP seeking new opportunities please call our dedicated team today 01908 326 400.

01908 326 400 www.txmhealthcare.co.uk

25

A-Z LISTING 2019

26

4ways Healthcare

836

Mermaid Medical Ltd

363

Agfa HealthCare UK Limited

338

Micrima

261

Amoena

480

MRS Systems, Inc.

440

APC Cardiovascular Ltd

336

Noras MRI products GmbH

844

Bracco UK

135

O3 Health Ltd

984

Breast Cancer Now

488

Oncotherm Kft.

362

CAE Healthcare

340

Oralieve UK

280

Cancer Center

954

P14 Medical Ltd

534

Caragen Ltd

492

Paxman

274

CERCA

294

Pharma Medico Ltd

286

Clatterbridge Private Clinic

266

Philips

630

ClearTrace

448

Planmed

134

Combinostics

846

Ratti

284

Datar Cancer Genetics

282

Raysafe

558

Derwent Healthcare Ltd

667

Roche Diagnostics Information Solutions

856

Diagnostic Healthcare Ltd

436

Rothband

542

EIZO Limited

642

Rutherford Cancer Centres

570

EMS Healthcare

260

Samsung NeuroLogica

238

EMTensor GmbH

437

Sky Factory

538

EndoSoft

370

Soliton IT

530

Everlight Radiology

554

Sterylab S.R.L.

566

Fairford Medical Limited

643

Telemedicine Clinic

257

Flen Health Ltd

872

The Leeds Gamma Knife Centre

680

GenesisCare

380

The Royal Marsden NHS Foundation Trust

490

iCAD, Inc.

840

484

ICU UK Medical Ltd

272

The Swallows Head & Neck Cancer Support Charity

InHealth Group

842

Throat Cancer Foundation

741

Interact Medical

828

Trycare

270

JCA Medical Seminar

559

TTM Healthcare

250

Jusha Displays

246

TXM Healthcare

242

LANDAUER

558

Varian Medical Systems

781

LBN Medical

550

ViewRay, Inc.

980

Maggie's

290

Vital Images Europe

255

MEDICA Group

729

Water-Jel Europe LLP

684

MedInfomatics

852

Xograph Healthcare

725

Medopad

264

Zendra Health

866

Merit Medical

581

FLOORPLAN 2019 Theatre 11 Breast GU Head & Neck Theatre 10 Radiation

884

684

886

980

783

680

580

04

581

380

286

282

280

274

276 271

Theatre 12 GI, Lung & IMUNO

482

484

781

284

682 480

872

954

660

667

Sales Office 864

572

570

Transforming Cancer Care Masterclass

860

452

370

272 270

866 856

852

142

760 564

566

562

560

JCA Theatre

Networking Area

362

264

363

262

266

848

Theatre 9 AI

729

558

630

846

844

840

842

255

559

554

448

250

440

340

838

261

Theatre 13 Imaging

257

Organisers Office

03 634

550

Networking Area

551

542

725

532

643

642

246

Theatre 14 Imaging

Sponsored By

836

828

538

Keynote Theatre

Sponsored By

Seating Area

260

242

546

534

437

436

239

238

134

234

236

131

232

230

135

338 438

439

336

435

Press Area

629 924

722

826

724

528

521

433

432

334

428

332

330

628 726

Theatre 8 Brain Stimulation

822

03

720

920

424

Thuasne Masterclass

526

520

816

132

01

420 600

903 900 710

130

510

511

324

321

224

220

113 16

320

810 322

222

112

901

110 14

Live Demo Theatre 7 Mental Health

VISITORS ENTRANCE

530

727

806

804

704

706

702

700

501

502

314

800

214

216

102 101

12

300

500 802

301

210

302

100

104

11

103 10

02

01 REHABILITATION

50

Theatre 6 Diagnostics & Monitoring

Theatre 5 Rehabilitation

University of Plymouth Masterclass

32

30

20

Theatre 3 Rehabilitation

02 DIAGNOSTICS & MONITORING / MENTAL HEALTH & BRAIN STIMULATION

Theatre 2 Rehabilitation

03 IMAGING

04 ONCOLOGY

SPONSORS

PARTNERS

27

Imaging Imaging

No bounds.

Better healthcare.

Through continuous collaboration with our customers, we’re connecting data and technology to empower the people behind the image.

During our sponsored speaker sessions, hear directly from clinicians as they share their experiences using our solutions and visit us on stand to see a showcase of innovation - all of which are designed to address your imaging challenges.

There’s always a way to make life better.

www.philips.co.uk/seamlessradiology

Find out more visit us on stand 630

Ad_half page_Front view_expo.pdf 1 04.01.2019 11:30:00

Come and see us in the Exhibition area

Evolving Medical Imaging • A new radio-wave breast imaging modality • Performs better than mammography in dense tissue • Provides new information to identify lesion types • Safe, effective and comfortable

+44 (0)117 251 0032 micrima.com

Fitted with

PPE Management System

The Original Radiation Protection Manufacturer - EST 1860 APRONS - CUSTOM DESIGNS - GLASSES - TABLE SCREENS - MOBILE SCREENS

Incorporating

Meeting the highest standards, at a lighter weight

Amoena recovery care bras offer soft, gentle compression for the best possible result after breast surgery.

See Amoena’s full range of compressions bras, recovery care products and silicone enhancers at www.amoena.co.uk

PERFECT SUPPORT RIGHT FROM THE START

www.amoena.co.uk

Offering the best for your patient

 Flexibility and Comfort  Antibacterial Upholstery  Optimal Arm Rest Adjustment

Protect your business from cyber attacks Identify vulnerabilties in your system with the Cyber Essentials scheme, available from as little as £300.

Call us:

A New Dimension in Safety Design & Comfort Please visit us at stand no 667 at the European Oncology Convention 2019

therapychair.com

derwenthealthcare.com

+44 (0)333 800 7000

Email: health@itgovernance.co.uk

Protect • Comply • Thrive

Visit us at stand 546

Radiographer opportunities nationwide General X-Ray, Theatres, CT, MRI, Mammography, Ultrasound, Cardiac CT Scan, Radiotherapy A career at Spire Healthcare offers excellent education and career development and this is an exciting time to be joining our expanding teams. A flexible working pattern is available allowing a desirable work life balance and you will have access to an extensive benefits programme.

You will have the opportunity to work with the latest generation diagnostic equipment, developing your skills and experience in a modern and supportive environment.

We have opportunities across the full range of Diagnostic Imaging and welcome Radiographers looking to cross train.

Visit us on Stand 134 and meet our experienced Radiographers to discuss the vast array of career and development opportunities available.

For us, it’s more than just treating patients; it’s about looking after people.

For more information contact our recruitment team at recruitment@spirehealthcare.com or visit www.spirelookingafteryou.co.uk